We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Two Simple Tests Help Pinpoint Cause of Stroke

By LabMedica International staff writers
Posted on 24 Jan 2018
About 85% of spontaneous intracerebral hemorrhages have no underlying macrovascular cause and are attributed to small vessel disease, mostly arteriolosclerosis with or without cerebral amyloid angiopathy (CAA).

Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan. More...
This new approach could revolutionize the way doctors manage strokes caused by bleeding in the brain, known as intracerebral hemorrhage (ICH).

Physicians at the University of Edinburgh (Edinburgh, UK) and their colleagues prospectively identified all incident cases of ICH with multiple overlapping sources of case ascertainment. They included consecutive adult patients (aged ≥16 years) with first-ever ICH by computerized tomography (CT). The team aimed to develop a multivariable prediction model for identifying lobar ICH associated with CAA using CT and genetic features, internally validate the model, and assess the diagnostic accuracy of different cutoffs to rule in and rule out CAA-associated intracerebral hemorrhage.

The doctors obtained DNA from peripheral blood samples or cerebellar tissue stored in the LINCHPIN brain bank with standard methods. They classified Apolipoprotein E (APOE) genotype as APOE ɛ2 possession if participants had at least one ɛ2 allele or APOE ɛ4 possession if they had at least one ɛ4 allele. Genotypes for two APOE single-nucleotide polymorphisms (rs429358 and rs7412) were determined using TaqMan single-nucleotide polymorphism genotyping assays on a QuantStudio 12K Flex Real Time polymerase chain reaction (PCR) system instrument.

The team found that among 110 adults (median age 83 years, 49 [45%] men) included in the study between June 1, 2010 and Feb 10, 2016, intracerebral hemorrhage was lobar in 62 (56%) participants, deep in 41 (37%), and infratentorial in seven (6%). Of the 62 participants with lobar intracerebral hemorrhage, 36 (58%) were associated with moderate or severe CAA compared with 26 (42%) that were associated with absent or mild CAA, and were independently associated with subarachnoid hemorrhage, 32/36 (89%) versus11/26 (2%), intracerebral hemorrhage with finger-like projections and APOE ɛ4 possession, 18/36 (50%) versus 2/26 (8%).

Mark A Rodrigues, MB ChB, FRCR, the lead author of the study said, “Identifying the cause of a brain hemorrhage is important to planning patient care. Our findings suggest that the combination of routine CT scanning with APOE gene testing can identify those whose ICH has been caused by CAA, a group who may be more at risk of another ICH or dementia.” The study was published on January 10, 2018, in the journal Lancet Neurology.

Related Links:
University of Edinburgh


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.